Study design. This prospective, randomized, controlled, parallel-group study compared the use of pen devices with conventional vials and syringes for the administration of insulin in hospitalized ...
Using data from a nationally representative sample, investigators sought to determine trends in insulin device use. In the past 5 years, ambulatory insulin use among patients with type 2 diabetes (T2D ...
Medtronic. Dexcom. Abbott. Sanofi. Google. A lot of very large, well-known companies are investing heavily into innovating the diabetes space, and that innovation is exciting. But a disproportionate ...
Please provide your email address to receive an email when new articles are posted on . The MiniMed Go app received FDA 510(k) clearance for people with type 1 or type 2 diabetes requiring insulin.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results